Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-15-007250
Filing Date
2015-01-28
Accepted
2015-01-28 21:12:18
Documents
2
Period of Report
2015-01-28

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 4373
2 POA DOCUMENT poa.txt EX-24.3_557030 3136
  Complete submission text file 0001209191-15-007250.txt   8892
Mailing Address 800 BOYLSTON STREET 24TH FLOOR BOSTON MA 02199
Business Address 800 BOYLSTON STREET 24TH FLOOR BOSTON MA 02199 617-874-1821
Flex Pharma, Inc. (Issuer) CIK: 0001615219 (see all company filings)

EIN.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O FLEX PHARMA, INC. 800 BOYLSTON STREET, 24TH FLOOR BOSTON MA 02199
Business Address
Hadfield Robert (Reporting) CIK: 0001630687 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36812 | Film No.: 15556571